iSpecimen
ISPC
11 hedge funds and large institutions have $653K invested in iSpecimen in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
15% less funds holding
Funds holding: 13 → 11 (-2)
16% less capital invested
Capital invested by funds: $781K → $653K (-$128K)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CA
Claro Advisors
Boston,
Massachusetts
|
+$26.8K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.44K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$18K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$9K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$1.22K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $225K | – | – | – |
|
|
BL
2
Bleichroeder LP
New York
| $90.5K | – | – | – |
|
|
GC
3
Grimes & Company
Westborough,
Massachusetts
| $90.2K | – | – | – |
|
4
BlackRock
New York
| $78K | – | – | – |
|
|
TA
5
Teton Advisors
Rye,
New York
| $55K | – | – | – |
|
6
Geode Capital Management
Boston,
Massachusetts
| $29K | – | – | – |
|
|
SSA
7
Schonfeld Strategic Advisors
New York
| $28.3K | – | – | – |
|
|
CA
8
Claro Advisors
Boston,
Massachusetts
| $23.8K | +$26.8K | +22 | New |
|
|
MSFS
9
Main Street Financial Solutions
Newtown,
Pennsylvania
| $14K | – | – | – |
|
10
Morgan Stanley
New York
| $11K | – | – | – |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $8K | +$2.44K | +2 | +40% |
|
12
Wells Fargo
San Francisco,
California
| $56 | – | – | – |
|
|
13
Bank of America
Charlotte,
North Carolina
| $16 | -$1.22K | -1 | Closed |
|
|
VF
14
Virtu Financial
New York
| – | -$18K | -13 | Closed |
|
|
15
UBS Group
Zurich,
Switzerland
| – | -$9K | -7 | Closed |
|
ISPC Hedge Fund Activity: Q4 2022 in Review
11 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in iSpecimen (ISPC) for Q4 2022, worth a combined $653K — down 16% from $781K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ISPC and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Claro Advisors, opening a new position worth an estimated $26.8K. The largest seller was Virtu Financial, exiting entirely with an estimated $18K sold.
- 11 institutional investors held iSpecimen (ISPC) as of Q4 2022, down from 13 in Q3 2022.
- Funds reported $653K of iSpecimen stock for Q4 2022, down 16% quarter-over-quarter.
- 1 fund opened new iSpecimen positions in Q4 2022 and 3 closed out, a net change of -2 holders.
- The largest iSpecimen buyer in Q4 2022 was Claro Advisors, an estimated $26.8K added.
- The largest iSpecimen seller in Q4 2022 was Virtu Financial, an estimated $18K sold.
Based on aggregated 13F filings for Q4 2022.